ArticleBlood advances2023

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis.

Ashley Aaroe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.